Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 08:33:00 +0200Fri, 28 Jun 2024 12:00:41 +0200Summary of opinion: Tepkinly, 27/06/2024 Positivehttps://www.ema.europa.eu/en/medicines/human/variation/tepkinlySummary of opinion: Tepkinly, 27/06/2024 Positivehttps://www.ema.europa.eu/en/medicines/human/variation/tepkinlyFri, 28 Jun 2024 12:00:41 +0200Human medicineHuman medicines European public assessment report (EPAR): Tepkinly, epcoritamab, Date of authorisation: 22/09/2023, Revision: 1, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/tepkinlyHuman medicines European public assessment report (EPAR): Tepkinly, epcoritamab, Date of authorisation: 22/09/2023, Revision: 1, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/tepkinlyWed, 17 Apr 2024 13:40:00 +0200Human medicineTepkinly : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5985-en.pdfTepkinly : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5985-en.pdfWed, 17 Apr 2024 13:35:00 +0200Human medicine